McKesson Corp (MCK)

McKesson Corp (MCK-N) is recognized as the largest distributor of pharmaceutical drugs in the US, dominating the market with its top competitors. Experts highlight its stability and predictable earnings growth, driven by an aging demographic and essential healthcare needs. Despite a recent rotation out of healthcare stocks, analysts expect a solid earnings growth of 12-13%, and note that the company’s forward P/E ratio is relatively undemanding, suggesting it isn't overpriced. The company is poised for potential growth with planned spin-offs of its medical and surgical unit, offering a catalyst for unlocking hidden value. Additionally, investors appreciate McKesson's strong dividend history, with yields of approximately 0.40-0.45% and consistent dividend growth over the past five years.